Article
Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Sept 2004
Budak-Alpdogan Tulin, Alpdogan Onder, Banerjee Debabrata, Wang Eunice, Moore Malcolm A S, Bertino Joseph R
Abstract excerpt
An SFG-based retroviral bicistronic vector containing a double-mutant dihydrofolate reductase-cytidine deaminase fusion cDNA (F/S DHFR-CD) with IRES-eGFP confers resistance to both methotrexate (MTX) and cytarabine (ara-C). Two weeks after transplantation with marrow transduced with either a fusion or a control gene (eGFP-IRES-NeoR), human lymphoma (SKI-DLCL-1) cells were injected sc into the flanks of nonobese...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
